prescribing information for these medications, meaning many patients who have experienced shedding may not have connected it to their prescription
Some people seem to be particularly responsive to GLP-1 therapy, potentially due to genetic factors affecting GLP-1 receptor density or sensitivity
Unlike older growth hormone-releasing peptides (such as GHRP-6), Ipamorelin is highly selective and does not activate the brains appetite-stimulating receptors, making it ideal for patients trying to lose weight
however, it too has been withdrawn from the market due to an association with bowel ischemia and for possible cardiovascular side effects
When their sleep was restricted to about 5.5 hours per night, the amount of fat lost dropped by 55%, even though calorie intake stayed the same (Nedeltcheva et al., Annals of Internal Medicine , 2010)